October 2005
Worldwide Biotech;Oct2005, Vol. 17 Issue 10, p1
Trade Publication
Reports on a licensing and distribution agreement signed by Labopharm Inc. with Purdue Pharma LP as of October 2005. Terms of the deal; Details of Labopharm's planned commercialization program for once-daily formulation of tramadol; Background information on tramadol.


Related Articles

  • LABOPHARM GRANTS TRAMDOL MARKETING RIGHTS TO PURDUE PHARMA.  // Worldwide Biotech;Jul2006, Vol. 18 Issue 7, p4 

    Reports on a definitive licensing and distribution agreement between Labopharm Inc. and Purdue Pharma L.P. for the marketing and distribution of Labopharm's once-daily formulation of the analgesic tramadol in the U.S. Terms of the agreement; Significance of the agreement to the need for more...

  • Pharma: Other News To Note.  // BioWorld Today;5/29/2013, Vol. 24 Issue 102, p12 

    The article offers news briefs on the pharmaceutical industry including the licensing agreement of Grunenthal Group with Purdue Pharma LP and a definitive agreement between Valeant Pharmaceuticals International Inc. and Bausch & Lomb Holdings Inc.

  • The Industry.  // Pharmaceutical Representative;Nov2005, Vol. 35 Issue 11, p10 

    The article reports on developments relevant to companies in the pharmaceutical industry as of November 2005. Biogen Idec plans a 17% reduction in staffing and sale of its psoriasis drug Amevive as part of a strategic initiative. Labopharm Inc. and Purdue Pharma LP announced a definitive U.S....

  • NEWS HEADLINES: Pain.  // PharmaWatch: CNS;March 2003, Vol. 2 Issue 3, p28 

    Presents news headlines on pain. Positive results achieved by Labopharm Inc. from the clinical trial for the analgesic, tramadol; Formal warning received by Purdue Pharma LP from the U.S. Food and Drug Administration that the press campaign for its OxyContin painkiller did not sufficiently...

  • LABOTHERM/PURDUE PHARMA SIGN TRAMADOL PACT.  // Biotech Business;Oct2005, Vol. 18 Issue 10, p8 

    Reports on an agreement entered into by pharmaceutical firm Labopharm Inc. with distributor Purdue Pharma LP, which deals with the distribution of the analgesic tramadol. Views of Labopharm Inc. president and CEO James R. Howard-Tripp on the marketing partnership between the firms; Value of...

  • OUT OF THE LAB AND INTO THE COURTS. Ross, Warren // Medical Marketing & Media;Oct2004, Vol. 39 Issue 10, p46 

    Reports on the controversy over GlaxoSmithKline's Paxil, a drug used for treating anxiety and depression and Purdue's narcotic analgesic, OxyContin. Lawsuit filed by Apotex against GlaxoSmithKline; endo's infringement of Purdue's OxyContin patent. INSETS: The Hatch-Wax man assault on...

  • Court battles continues in painkiller rivalry. Kirsche, Michelle L. // Drug Store News;2/16/2004, Vol. 26 Issue 2, p49 

    Reports that painkiller OxyContin is making headlines again after a judge ruled patents on the drug are unenforceable, opening the floodgates to imminent generic competition. Appeal by Purdue Pharma, the maker of OxyContin; Ruling by U.S. District Judge Sidney Stein on January 5, 2004.

  • Oxy maker searches for the next Oxy. Soule, Alexander // Fairfield County Business Journal;5/28/2007, Vol. 46 Issue 22, p1 

    The article reports on the effort of Purdue Pharma Inc. to develop a new pain medication to address the controversy in the marketing of oxycontin pill in the U.S. Palladone was developed for use by patients who had built a tolerance to oxycontin and other opioid drugs that is twice as powerful...

  • Phurdu Pharma will add 250 jobs at Ardsley campus. Philippidis, Alex // Westchester County Business Journal;12/15/97, Vol. 36 Issue 50, p1 

    Reports that Purdue Pharma L.P. is looking to create 250 additional jobs and purchase more space at Ardsley Park Science and Technology Center. Talks on purchase of a second building at the former Ciba-Geigy campus; Value of the invsetment that Purdue Pharma will put into Ardsley Park:...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics